中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/08 | 5,171 | 5,421 | 5,171 | 5,420 | +227 | +4.4% | 3,299,400 |
| 2024/02/07 | 5,085 | 5,245 | 5,075 | 5,193 | +65 | +1.3% | 1,890,400 |
| 2024/02/06 | 5,090 | 5,150 | 5,061 | 5,128 | +4 | +0.1% | 2,485,400 |
| 2024/02/05 | 5,210 | 5,213 | 5,043 | 5,124 | -62 | -1.2% | 3,089,700 |
| 2024/02/02 | 5,261 | 5,345 | 5,084 | 5,186 | -124 | -2.3% | 3,789,600 |
| 2024/02/01 | 5,332 | 5,375 | 5,267 | 5,310 | -37 | -0.7% | 1,759,000 |
| 2024/01/31 | 5,297 | 5,358 | 5,280 | 5,347 | -23 | -0.4% | 2,235,200 |
| 2024/01/30 | 5,490 | 5,501 | 5,330 | 5,370 | -80 | -1.5% | 1,871,000 |
| 2024/01/29 | 5,450 | 5,502 | 5,433 | 5,450 | +34 | +0.6% | 1,461,900 |
| 2024/01/26 | 5,450 | 5,485 | 5,401 | 5,416 | -39 | -0.7% | 1,636,300 |
| 2024/01/25 | 5,474 | 5,512 | 5,383 | 5,455 | -119 | -2.1% | 2,059,000 |
| 2024/01/24 | 5,583 | 5,607 | 5,526 | 5,574 | -52 | -0.9% | 1,335,700 |
| 2024/01/23 | 5,581 | 5,705 | 5,576 | 5,626 | +28 | +0.5% | 1,479,500 |
| 2024/01/22 | 5,613 | 5,650 | 5,544 | 5,598 | +57 | +1% | 1,882,000 |
| 2024/01/19 | 5,645 | 5,677 | 5,497 | 5,541 | -92 | -1.6% | 2,193,500 |
| 2024/01/18 | 5,667 | 5,705 | 5,620 | 5,633 | -76 | -1.3% | 2,114,000 |
| 2024/01/17 | 5,869 | 5,920 | 5,709 | 5,709 | -207 | -3.5% | 3,403,800 |
| 2024/01/16 | 5,928 | 5,974 | 5,887 | 5,916 | -19 | -0.3% | 1,412,500 |
| 2024/01/15 | 5,892 | 5,968 | 5,841 | 5,935 | +48 | +0.8% | 1,644,500 |
| 2024/01/12 | 6,035 | 6,035 | 5,868 | 5,887 | +52 | +0.9% | 3,904,100 |
| 2024/01/11 | 5,781 | 5,865 | 5,756 | 5,835 | +167 | +2.9% | 2,785,800 |
| 2024/01/10 | 5,570 | 5,694 | 5,505 | 5,668 | +116 | +2.1% | 2,053,100 |
| 2024/01/09 | 5,487 | 5,627 | 5,449 | 5,552 | +164 | +3% | 2,603,400 |
| 2024/01/05 | 5,398 | 5,428 | 5,366 | 5,388 | +8 | +0.1% | 1,757,900 |
| 2024/01/04 | 5,307 | 5,380 | 5,247 | 5,380 | +38 | +0.7% | 2,277,300 |
| 2023/12/29 | 5,373 | 5,414 | 5,295 | 5,342 | -44 | -0.8% | 1,603,000 |
| 2023/12/28 | 5,344 | 5,401 | 5,298 | 5,386 | +2 | ±0% | 1,051,400 |
| 2023/12/27 | 5,357 | 5,423 | 5,330 | 5,384 | +29 | +0.5% | 1,932,400 |
| 2023/12/26 | 5,349 | 5,364 | 5,305 | 5,355 | +6 | +0.1% | 1,144,600 |
| 2023/12/25 | 5,338 | 5,370 | 5,304 | 5,349 | +34 | +0.6% | 727,000 |
| 2023/12/22 | 5,276 | 5,342 | 5,246 | 5,315 | +20 | +0.4% | 1,631,600 |
| 2023/12/21 | 5,367 | 5,381 | 5,277 | 5,295 | -155 | -2.8% | 1,653,500 |
| 2023/12/20 | 5,333 | 5,487 | 5,322 | 5,450 | +117 | +2.2% | 2,060,800 |
| 2023/12/19 | 5,326 | 5,344 | 5,241 | 5,333 | +29 | +0.5% | 1,978,600 |
| 2023/12/18 | 5,278 | 5,354 | 5,248 | 5,304 | -40 | -0.7% | 1,584,800 |
| 2023/12/15 | 5,362 | 5,449 | 5,297 | 5,344 | -64 | -1.2% | 2,815,500 |
| 2023/12/14 | 5,396 | 5,429 | 5,366 | 5,408 | +71 | +1.3% | 2,098,900 |
| 2023/12/13 | 5,364 | 5,374 | 5,275 | 5,337 | -20 | -0.4% | 2,597,600 |
| 2023/12/12 | 5,347 | 5,428 | 5,330 | 5,357 | +1 | ±0% | 2,324,000 |
| 2023/12/11 | 5,400 | 5,455 | 5,344 | 5,356 | -10 | -0.2% | 1,857,100 |
| 2023/12/08 | 5,405 | 5,426 | 5,314 | 5,366 | -75 | -1.4% | 3,618,400 |
| 2023/12/07 | 5,430 | 5,449 | 5,370 | 5,441 | +1 | ±0% | 2,214,300 |
| 2023/12/06 | 5,297 | 5,440 | 5,281 | 5,440 | +206 | +3.9% | 2,333,100 |
| 2023/12/05 | 5,288 | 5,305 | 5,221 | 5,234 | -87 | -1.6% | 1,919,600 |
| 2023/12/04 | 5,121 | 5,321 | 5,101 | 5,321 | +112 | +2.2% | 2,614,100 |
| 2023/12/01 | 5,244 | 5,293 | 5,197 | 5,209 | -9 | -0.2% | 1,690,400 |
| 2023/11/30 | 5,068 | 5,238 | 5,052 | 5,218 | +150 | +3% | 5,052,900 |
| 2023/11/29 | 5,008 | 5,082 | 4,989 | 5,068 | +54 | +1.1% | 1,495,600 |
| 2023/11/28 | 4,989 | 5,019 | 4,919 | 5,014 | +14 | +0.3% | 2,066,700 |
| 2023/11/27 | 5,091 | 5,094 | 4,962 | 5,000 | -73 | -1.4% | 1,786,400 |
301～
350
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.24倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.48倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
